Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Angiopoietin-like Proteins | 3 | 2018 | 16 | 1.09 | Why? |
| Adipose Tissue | 2 | 2018 | 612 | 0.93 | Why? |
| Peptide Hormones | 2 | 2018 | 14 | 0.93 | Why? |
| Point Mutation | 1 | 2021 | 481 | 0.71 | Why? |
| Angiopoietins | 1 | 2017 | 45 | 0.68 | Why? |
| Viral Regulatory and Accessory Proteins | 1 | 2021 | 482 | 0.60 | Why? |
| Lipid Metabolism | 3 | 2020 | 572 | 0.41 | Why? |
| Adaptive Immunity | 1 | 2020 | 2585 | 0.37 | Why? |
| Diabetes Complications | 1 | 2020 | 2358 | 0.36 | Why? |
| Obesity | 2 | 2020 | 7388 | 0.35 | Why? |
| Biological Products | 1 | 2021 | 2331 | 0.31 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.26 | Why? |
| Furin | 2 | 2021 | 1054 | 0.26 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.26 | Why? |
| Viral Nonstructural Proteins | 1 | 2021 | 4810 | 0.25 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.24 | Why? |
| Molecular Dynamics Simulation | 4 | 2021 | 4155 | 0.22 | Why? |
| Palmitic Acid | 1 | 2019 | 28 | 0.20 | Why? |
| Mutant Proteins | 1 | 2020 | 328 | 0.19 | Why? |
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 12 | 0.18 | Why? |
| Palmitates | 1 | 2017 | 4 | 0.18 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.17 | Why? |
| Brain-Derived Neurotrophic Factor | 1 | 2017 | 133 | 0.16 | Why? |
| Insulin-Secreting Cells | 1 | 2019 | 273 | 0.16 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 372 | 0.16 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2019 | 385 | 0.16 | Why? |
| Neurofilament Proteins | 1 | 2017 | 202 | 0.16 | Why? |
| Lipocalin-2 | 1 | 2017 | 156 | 0.16 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.16 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.15 | Why? |
| Receptors, G-Protein-Coupled | 1 | 2019 | 309 | 0.15 | Why? |
| Methyltransferases | 1 | 2021 | 720 | 0.14 | Why? |
| Catalytic Domain | 1 | 2021 | 1757 | 0.14 | Why? |
| Protein Interaction Maps | 1 | 2021 | 1333 | 0.13 | Why? |
| Molecular Docking Simulation | 4 | 2021 | 6902 | 0.13 | Why? |
| Binding Sites | 2 | 2021 | 6201 | 0.11 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.11 | Why? |
| Metabolic Diseases | 1 | 2017 | 505 | 0.11 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.10 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2020 | 6166 | 0.09 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.08 | Why? |
| Drug Discovery | 1 | 2021 | 3092 | 0.08 | Why? |
| Thermodynamics | 2 | 2020 | 873 | 0.08 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.08 | Why? |
| Serine Endopeptidases | 1 | 2020 | 4606 | 0.07 | Why? |
| Protein Binding | 4 | 2021 | 11430 | 0.07 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.06 | Why? |
| Multiple Sclerosis | 1 | 2017 | 2600 | 0.06 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.06 | Why? |
| Biosynthetic Pathways | 1 | 2020 | 97 | 0.05 | Why? |
| Kuwait | 1 | 2020 | 306 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.05 | Why? |
| Humans | 12 | 2021 | 930598 | 0.05 | Why? |
| Remyelination | 1 | 2017 | 35 | 0.05 | Why? |
| Endocytosis | 1 | 2020 | 451 | 0.04 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.04 | Why? |
| Natalizumab | 1 | 2017 | 144 | 0.04 | Why? |
| Fingolimod Hydrochloride | 1 | 2017 | 217 | 0.04 | Why? |
| Demyelinating Diseases | 1 | 2017 | 224 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2017 | 8207 | 0.04 | Why? |
| Virulence | 1 | 2021 | 2172 | 0.03 | Why? |
| Adult | 4 | 2020 | 244371 | 0.03 | Why? |
| Middle Aged | 4 | 2020 | 270681 | 0.03 | Why? |
| Rats | 1 | 2019 | 2764 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.03 | Why? |
| Male | 4 | 2020 | 367725 | 0.03 | Why? |
| Female | 4 | 2020 | 380317 | 0.02 | Why? |
| Sex Characteristics | 1 | 2017 | 1120 | 0.02 | Why? |
| Apoptosis | 1 | 2019 | 2335 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2020 | 3607 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Signal Transduction | 1 | 2019 | 7207 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Animals | 2 | 2020 | 78931 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Aged | 1 | 2020 | 215776 | 0.00 | Why? |
Abubaker's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(53)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_